You just read:

AbbVie Demonstrates Leadership in HCV with New MAVYRET™ (glecaprevir/pibrentasvir) Data to be Presented at The Liver Meeting® 2017

News provided by

AbbVie

Oct 11, 2017, 14:57 ET